Financing - April 20, 2020
IRRAS raises 217 million SEK
IRRAS announces outcome of the fully guaranteed rights issue of 217 million SEK. “During these unprecedented SARS-CoV-2 times across the globe, IRRAS’ focus remains on the patients and physicians who need our support and access to our neurocritical care products,” said Kleanthis G. Xanthopoulos, President & CEO of IRRAS. “This round of financing and outcome […]
Financing - March 26, 2020
The Stockholm Material Hub receives 0.5 MEUR from European Regional Development Fund
The Stockholm Material Hub (SMH) has secured funding from the EU’s European Regional Development Fund, enabling continued research into novel materials and their use in life science applications. SMH is coordinated by Stockholm University (SU) and integrates materials expertise existing in Royal Institute of Technology (KTH), Karolinska Institute (KI) and other academic institutions. The vision […]
Financing - March 16, 2020
iCellate Medical and Elthera receives 25 million SEK grant
Swedish iCellate Medical has together with the Swiss biopharmaceutical company Elthera (and consortium) received a grant of 25 MSEK from Eurostars to develop a new second generation immunotherapy drug for pancreatic and ovarian cancers. In the evaluation process Eurostars rated iCellate’s project as the most interesting among all Swedish applicants, states the company in its […]
Financing - March 12, 2020
Cinclus Pharma raises SEK 250 million
Cinclus Pharma has completed a financing round of SEK 250 million to fund the further clinical development of X842, a clinical-stage drug candidate for the treatment of gastroesophageal reflux disease (GERD). The Fourth Swedish National Pension Fund (AP4) joined as a new major shareholder through the issue, which was also subscribed by, among others, the […]
Financing - March 11, 2020
Capitainer raises SEK 15 million
Medtech start-up, Capitainer, has announced that it has closed a share issue of SEK 15 million to commersialize its new dried blood spot sampling solution. Lead investors are Nordic Consumer Health and the US-based Wolf Family Trust, joined by a consortium of Nordic angel investors and Capitainer management. “The dried blood spot collection card market […]
Financing - March 5, 2020
Lundbeck receives grant from The Michael J. Fox Foundation
Lundbeck will begin research on a novel method for earlier and more precise diagnosis of Parkinson’s disease, the likes of which do not currently exist. By diagnosing Parkinson’s disease as early as possible, patients can benefit from a greater choice in treatment options. This research is funded by The Michael J. Fox Foundation for Parkinson’s […]
